The FDA announced today that it authorized the Q-Collar made by Q30 Sports Science for protecting the brain during sports activities. Q30 Sports Science’s Q-Collar is a C-shaped collar worn around the neck designed to apply compressive force to the neck and increase blood volume to help reduce movement of the brain within the cranial […]
Sports Medicine
NHL to use X2 Biosystems concussion evaluation software
The National Hockey League plans to supply all 30 of its teams this season with X2 Biosystems head injury detection software, appropriately dubbed "ICE" for "integrated concussion evaluation."
Surgical Frontiers incubator raises $7M

Surgical Frontiers is looking to make investments in young musculoskeletal technology companies with the $7 million fund it just secured.
The company has already promised some of the cash to 3 portfolio companies with orthopedic technologies in foot & ankle, sports medicine and trauma, the company said.
Stryker quietly closes Pivot Medical buy
Stryker boosts sports medicine biz with Pivot Medical buy


Smith & Nephew may face rivals in $1.7B bid for ArthroCare

Smith & Nephew expands sports medicine footprint with $1.7B ArthroCare buy


X2 Biosystems seeks $5 million for concussion patch

X2 Biosystems is looking to bring in $5 million in a new funding round.
The Seattle-based medical device company is offering debt and options in this round. The company has yet to attract investors, according to a regulatory filing.
X2 Biosystems aims for $12.5M funding round

X2 Biosystems, a medical device company that’s developing sensors for sports brain injuries, drummed up $3.3 million of a hoped-for $12.5 million raise, according to a regulatory filing.
Eighteen unnamed investors kicked in on the round, according to the filing.
FDA reschedules orthopedic panel meeting

The FDA rescheduled a meeting of its Orthopedic & Rehabilitation Devices Panel, originally slated for April 5, to discuss reclassifying shortwave diathermy devices and pedicle screws.
The shortwave diathermy meeting is now scheduled for May 21 in Gaithersburg, Md., the agency said.